These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 27042728)

  • 1. Insulin lispro (HUMALOG KWIKPEN) double concentration (200 units/ml). Risk of confusion.
    Prescrire Int; 2016 Feb; 25(168):40. PubMed ID: 27042728
    [No Abstract]   [Full Text] [Related]  

  • 2. A comparison of glide force characteristics between 2 prefilled insulin lispro pens.
    Rees TM; Lennartz AH; Ignaut DA
    J Diabetes Sci Technol; 2015 Mar; 9(2):316-9. PubMed ID: 25591858
    [TBL] [Abstract][Full Text] [Related]  

  • 3. U-200 Humalog Insulin Now Available in United States.
    Chabanuk AJ
    Home Healthc Now; 2016 Feb; 34(2):102. PubMed ID: 26835809
    [No Abstract]   [Full Text] [Related]  

  • 4. [Humalog® 200 U/ml KwikPen™].
    Scheen AJ
    Rev Med Liege; 2015 Oct; 70(10):527-31. PubMed ID: 26727843
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of metabolic and mitogenic response in vitro of the rapid-acting insulin lispro product SAR342434, and US- and EU-approved Humalog®.
    Korn M; Wohlfart P; Gossas T; Kullman-Magnusson M; Niederhaus B; Dedio J; Tennagels N
    Regul Toxicol Pharmacol; 2019 Dec; 109():104497. PubMed ID: 31610222
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A study comparing insulin lispro mix 25 with glargine plus lispro therapy in patients with Type 2 diabetes who have inadequate glycaemic control on oral anti-hyperglycaemic medication: results of the PARADIGM study.
    Bowering K; Reed VA; Felicio JS; Landry J; Ji L; Oliveira J
    Diabet Med; 2012 Sep; 29(9):e263-72. PubMed ID: 22672081
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retinopathy risk: what is responsible? Hormones, hyperglycemia, or humalog? Response to Kitzmiller et al.
    Jovanovic L
    Diabetes Care; 1999 May; 22(5):846-8. PubMed ID: 10332693
    [No Abstract]   [Full Text] [Related]  

  • 8. Analysis of "Dose Accuracy, Injection Force, and Usability Assessment of a New Half-Unit, Prefilled Insulin Pen".
    Bariya M; Nayberg I
    J Diabetes Sci Technol; 2018 Mar; 12(2):373-375. PubMed ID: 29281890
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Humalog--human kindling?
    MacInnis BJ
    Can J Ophthalmol; 1998 Oct; 33(6):303-5. PubMed ID: 9818125
    [No Abstract]   [Full Text] [Related]  

  • 10. Integrating advances in insulin into clinical practice: Advances In insulin formulations.
    King A
    J Fam Pract; 2013 Sep; 62(9 Suppl Insulin):S9-17. PubMed ID: 24080573
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Basal insulin glargine vs prandial insulin lispro in type 2 diabetes.
    Oliveira JH; Kazda C; Simpson A; Jackson JA; Heine RJ
    Lancet; 2008 Aug; 372(9636):371-2; author reply 372. PubMed ID: 18675683
    [No Abstract]   [Full Text] [Related]  

  • 12. Humalog Mix 25 in patients with type 2 diabetes which do not achieve acceptable glycemic control with oral agents: results from a phase III, randomized, parallel study.
    Tîrgovişte CI; Străchinariu R; Farcaşiu E; Milicevic Z; Teodorescu G
    Rom J Intern Med; 2003; 41(2):153-62. PubMed ID: 15526500
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Engineering study comparing injection force and dose accuracy between two prefilled insulin injection pens.
    Ignaut DA; Opincar MR; Clark PE; Palaisa MK; Lenox SM
    Curr Med Res Opin; 2009 Dec; 25(12):2829-33. PubMed ID: 19916727
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ease of use and patient preference injection simulation study comparing two prefilled insulin pens.
    Clark PE; Valentine V; Bodie JN; Sarwat S
    Curr Med Res Opin; 2010 Jul; 26(7):1745-53. PubMed ID: 20482243
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improved postprandial glycemic control in patients with type 2 diabetes from subcutaneous injection of insulin lispro with hyaluronidase.
    Hompesch M; Muchmore DB; Morrow L; Ludington E; Vaughn DE
    Diabetes Technol Ther; 2012 Mar; 14(3):218-24. PubMed ID: 22136324
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Humalog(®) KwikPen™: an insulin-injecting pen designed for ease of use.
    Schwartz SL; Ignaut DA; Bodie JN
    Expert Rev Med Devices; 2010 Nov; 7(6):735-43. PubMed ID: 21050084
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A case of suppurative granuloma induced by insulin injection.
    Tanizaki H; Matsumura Y; Tokura Y; Miyachi Y; Kabashima K
    Acta Derm Venereol; 2010 Sep; 90(5):540-1. PubMed ID: 20814643
    [No Abstract]   [Full Text] [Related]  

  • 18. Prolonged efficacy of short acting insulin Lispro in combination with human ultralente in insulin-dependent diabetes mellitus.
    Burge MR; Waters DL; Holcombe JH; Schade DS
    J Clin Endocrinol Metab; 1997 Mar; 82(3):920-4. PubMed ID: 9062507
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of insulin lispro and biosynthetic human insulin in pulmonary absorption: in vivo and in vitro studies.
    Fang F; Lu Y; Liang Y; Zhu J; He J; Zheng J; Li N; Tang Y; Zhu J; Chen X
    Pharmazie; 2012 Aug; 67(8):706-11. PubMed ID: 22957436
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Congenital anomaly rate in offspring of mothers with diabetes treated with insulin lispro during pregnancy.
    Wyatt JW; Frias JL; Hoyme HE; Jovanovic L; Kaaja R; Brown F; Garg S; Lee-Parritz A; Seely EW; Kerr L; Mattoo V; Tan M;
    Diabet Med; 2005 Jun; 22(6):803-7. PubMed ID: 15910635
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.